“fda” Archives

in
Entry Author Date Location
Senate Approves 21st Century Cures Act, Sending Bill to Obama 12/07/16 National
First Clinical Trial Done, Elysium Lands $20M for Health Supplements 12/06/16 New York
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update 12/05/16 National
Eli Lilly Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 12/02/16 Indiana
Boston Scientific to Buy Neovasc Heart Valve Assets in $75M Deal 12/02/16 Boston
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Arrowhead’s Future Could Now Ride on Progress of Amgen Partnership 11/30/16 Wisconsin
Brushing Aside Critics, House Votes in Landslide for Cures Act 11/30/16 National
Goldman Funnels $51M Into Cloud Tech Company That Fights Fake Drugs 11/30/16 Boston
Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies 11/29/16 National
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
Two More Deaths In Trial Halt Juno’s Top CAR-T Treatment Again 11/23/16 Seattle
Arrowhead, Microbes, Diabetes, & More: This Week’s WI Watchlist 11/18/16 Wisconsin
Seventh Sense Biosystems Sucks In $10M for Simple Blood-Draw Device 11/18/16 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Roundup: Geekdom, Prytime Medical, Hangar, Houston Startup Week, & More 11/16/16 Texas
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Prytime Medical Gets OK to Sell Anti-Hemorrhaging Device in Europe 11/14/16 Texas
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
Arrowhead Stock Falls After FDA Places Hold on Clinical Trial 11/09/16 Wisconsin
AquaBounty Charts Course to Market with $25M Intrexon Deal 11/07/16 Boston
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer 10/25/16 National
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
Endomag, European Device Makers Eye U.S. Amid Regulatory Changes 10/20/16 Texas
Eli Lilly Wins FDA Nod for New Soft Tissue Sarcoma Drug 10/20/16 Indiana
Arterys, GE Healthcare to Roll Out Next-Gen MRI Scans of Heart 10/19/16 San Francisco
Page 2 of 56 « previous page · next page »